Arciero V - Search Results

1

Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.

Dai WF, Arciero V, Craig E, Fraser B, Arias J, Boehm D, Bosnic N, Caetano P, Chambers C, Jones B, Lungu E, Mitera G, Potashnik T, Reiman A, Ritcher T, Beca JM, Denburg A, Mercer RE, Parmar A, Tadrous M, Takhar P, Chan KKW, On Behalf Of The CanREValue Collaboration Reassessment And Uptake Working Group. Dai WF, et al. Among authors: arciero v. Curr Oncol. 2021 Oct 16;28(5):4174-4183. doi: 10.3390/curroncol28050354. Curr Oncol. 2021. PMID: 34677272 Free PMC article.

2

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer.

Arciero V, Luo J, Parmar A, Dai WF, Beca JM, Raphael MJ, Isaranuwatchai W, Habbous S, Tadrous M, Earle CC, Biagi JJ, Mittmann N, Arias J, Gavura S, Chan KKW. Arciero V, et al. JNCI Cancer Spectr. 2022 Jul 1;6(4):pkac047. doi: 10.1093/jncics/pkac047. JNCI Cancer Spectr. 2022. PMID: 35758620 Free PMC article.

3

Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework.

Delos Santos S, Witzke N, Gyawali B, Arciero VS, Rahmadian AP, Everest L, Cheung MC, Chan KK. Delos Santos S, et al. Among authors: arciero vs. J Natl Compr Canc Netw. 2021 Feb 26;19(7):815-820. doi: 10.6004/jnccn.2020.7677. J Natl Compr Canc Netw. 2021. PMID: 33636693

4

Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time.

Saluja R, Arciero VS, Cheng S, McDonald E, Wong WWL, Cheung MC, Chan KKW. Saluja R, et al. J Oncol Pract. 2018 May;14(5):e280-e294. doi: 10.1200/JOP.17.00058. Epub 2018 Mar 30. J Oncol Pract. 2018. PMID: 29601250

5

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review.

Arciero V, Delos Santos S, Koshy L, Rahmadian A, Saluja R, Everest L, Parmar A, Chan KKW. Arciero V, et al. JAMA Netw Open. 2021 Feb 1;4(2):e2033004. doi: 10.1001/jamanetworkopen.2020.33004. JAMA Netw Open. 2021. PMID: 33570573 Free PMC article.

6

Do older and younger patients derive similar survival benefits from novel oncology drugs? A systematic review and meta-analysis.

Arciero VS, Cheng S, Mason R, McDonald E, Saluja R, Chan KKW. Arciero VS, et al. Age Ageing. 2018 Sep 1;47(5):654-660. doi: 10.1093/ageing/afy079. Age Ageing. 2018. PMID: 29788041

7

Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis.

Udayakumar S, Parmar A, Leighl NB, Everest L, Arciero VS, Santos SD, Rahmadian A, Doherty MK, Chan KKW. Udayakumar S, et al. Among authors: arciero vs. Crit Rev Oncol Hematol. 2022 May;173:103660. doi: 10.1016/j.critrevonc.2022.103660. Epub 2022 Mar 24. Crit Rev Oncol Hematol. 2022. PMID: 35341985 Review.

8

Do female and male patients derive similar benefits from approved systemic oncology therapies? A systematic review and meta-analysis.

Arciero V, McDonald E, Nguyen V, Saluja R, Raphael M, Parmar A, Chan KKW. Arciero V, et al. J Cancer Res Clin Oncol. 2023 Jul;149(8):4215-4224. doi: 10.1007/s00432-022-04270-0. Epub 2022 Sep 3. J Cancer Res Clin Oncol. 2023. PMID: 36056954

9

Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?

Cheng S, Cheung MC, Jiang DM, McDonald E, Arciero VS, Ezeife DA, Rahmadian A, Chambers A, Sabarre KA, Parmar A, Chan KKW. Cheng S, et al. Among authors: arciero vs. J Natl Compr Canc Netw. 2019 Dec;17(12):1489-1496. doi: 10.6004/jnccn.2019.7333. J Natl Compr Canc Netw. 2019. PMID: 31805528

10

Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?

Cheng S, McDonald EJ, Cheung MC, Arciero VS, Qureshi M, Jiang D, Ezeife D, Sabharwal M, Chambers A, Han D, Leighl N, Sabarre KA, Chan KKW. Cheng S, et al. J Clin Oncol. 2017 Aug 20;35(24):2764-2771. doi: 10.1200/JCO.2016.71.6894. Epub 2017 Jun 2. J Clin Oncol. 2017. PMID: 28574778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page